AGP Franklin’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Buy
12,941
+572
+5% +$75.4K 0.71% 43
2026
Q1
$1.72M Buy
12,369
+584
+5% +$81.8K 0.86% 39
2025
Q4
$1.45M Buy
11,785
+637
+6% +$77.4K 0.68% 48
2025
Q3
$1.24M Buy
+11,148
New +$1.27M 0.6% 53

Other funds holding GILD

AGP Franklin's GILD Position: Q2 2026 in Review

AGP Franklin increased its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, buying an estimated $75.4K and bringing the position to 12,941 shares worth $1.63M. The position accounts for 0.71% of the portfolio, ranked #43.

AGP Franklin first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.72M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AGP Franklin held 12,941 shares of Gilead Sciences worth $1.63M as of Q2 2026.
  • AGP Franklin bought 572 Gilead Sciences shares in Q2 2026, an estimated $75.4K.
  • Gilead Sciences made up 0.71% of AGP Franklin's portfolio in Q2 2026, its #43 holding.
  • AGP Franklin first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • AGP Franklin's Gilead Sciences position peaked at $1.72M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AGP Franklin's 13F filing for Q2 2026, filed 30 Jul 2026.